Annual Report

Overview

The report presents the company's FY2020-21 consolidated revenue of INR 5,393.13 Crores and continued expansion across its pharmaceutical businesses. It reports INR 17.60 Crores of CSR spending across healthcare, education, rural development and COVID-19 relief, alongside wind and solar power generation and energy-efficiency measures. The report also identifies a 12,160-person workforce and continued R&D and manufacturing-capacity investment.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020-2021
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services